- The Funding Letter
- Posts
- 💰The Funding Letter #1224: August 15
💰The Funding Letter #1224: August 15
Arcturus, Anthropic, d.light, and more...
Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from Weights & Biases below!
Hit the Gong 🎉
Source: @sales_humor
Daily Deals 💸
🌎 Americas
Arcturus Therapeutics is a global late-stage clinical mRNA medicine and vaccines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $115M, Grant
Round Investors: Japan - The Government of Japan (lead)
🚀Growth Focus: Accelerate the production of its mRNA vaccines and therapeutics.
Press: Business Wire, Fierce Pharma
HQ: San Diego, CA
Industry: Biotechnology Research
Employee Count: 215 (⚡13% increase in last 6 months)
Subscribe to TFL All-Access Tier to read the rest.
Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In.
A subscription gets you:
- • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
- • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
- • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
- • ..and much more to come!